Total Funding
66
63
Total FundingGrant raised
Growth Score
-6 pts
Heat Score
-9 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
100801
Stem Pharm's synthetic biomaterials support the optimization of cell expansion.
- William L. Murphy: Co-founder & Chief Science Officer
- Steve Visuri: CEOPast Role: FloraSeq, Co-founder
About the Company
Stem Pharm was founded in 2015 with the purpose of being a trusted supplier of synthetic biomaterials that are specifically designed to meet customer's requirements as they develop more advanced cellular models for drug discovery and toxicity screening and cellular therapies for regenerative medicine applications. Stem Pharm is located in the
Fitchburg Technology Campus, near the University of Wisconsin campus. It Leverages its expertise in biomaterials and cellular interactions to develop high-value applications of organoids (3-D in vitro models) for drug discovery and cell-friendly coatings for the manufacture of-cell based therapies.
